Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones06:00 ET

Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More

Seeking AlphaNov 18 00:09 ET

Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?

Simply Wall StNov 6 08:08 ET

Express News | HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $40 Price Target

BenzingaNov 4 06:29 ET

Anavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market Expansion

TipRanksNov 4 06:15 ET · Ratings

Anavex Life Sciences Shares Are Trading Higher After the Company Announced New Data From the Phase IIb/III Study Showing That Blarcamesine, Once Daily Orally, Demonstrates Pre-specified Clinical Efficacy Through Upstream SIGMAR1 Activation.

BenzingaOct 31 14:58 ET